Top Two Of The Day: Aduro Biotech, Inc. (NASDAQ:ADRO), Varex Imaging Corporation (NASDAQ:VREX)

Aduro Biotech, Inc. (NASDAQ:ADRO)

Aduro Biotech, Inc. (NASDAQ:ADRO) closed at $3.22 on the last trading session with an increase of 8.78%, whereas, it previously closed at $2.96. The company has a market capitalization of $228.1 Million. The company traded shares of 1.82 Million on the trading day while its three month average volume stands at 1.2 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Aduro Biotech, Inc. (NASDAQ:ADRO) produced diluted EPS of -1.12. The EPS estimate for next year as estimated by analysts is at -0.79 while EPS for next quarter is estimated at -0.21. Earnings per Share growth for this year is reported at 0.3, while the analysts estimated the EPS growth for next year at -0.79% and Earnings growth for next 5 years stands at 9% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -36.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Aduro Biotech, Inc. (NASDAQ:ADRO) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Aduro Biotech, Inc. (NASDAQ:ADRO) stands at 13.91 and Price to Book or P/B for the most recent quarter stands at 3.16. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Aduro Biotech, Inc. (NASDAQ:ADRO) are reported at 7.3 and 7.3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Aduro Biotech, Inc. (NASDAQ:ADRO) stands at -26.2, -82.3 and -74.3 respectively

The trailing twelve month Revenue of Aduro Biotech, Inc. (NASDAQ:ADRO) is reported at 16.4 Million with income of -89300000. The outstanding shares of Aduro Biotech, Inc. (NASDAQ:ADRO) are 70.84 Million. The institutional Ownership of the shares of 47.3 stands at 0.80%, this figure is increased 4.41 in the last six months. The insider ownership for the shares of Aduro Biotech, Inc. (NASDAQ:ADRO) is ticked at 1.2%, the figure is plummeted -14.84% in the last six months.

Some other important financial aspects to be discussed here for Aduro Biotech, Inc. (NASDAQ:ADRO) is the Mean Target Price estimated by the analysts which stands at 6.75. The 52 week high of Aduro Biotech, Inc. (NASDAQ:ADRO) is placed at 4.59 and 52 week low is standing at 0.90.

Performance wise the shares of Aduro Biotech, Inc. (NASDAQ:ADRO) rose up 27.52% for the week, it also rise 170.59% for the monthly performance, while for the quarter it went down 200.93%. The shares increase 149.61% for the half year and flew up for the Year-To-Date performance. The shares of Aduro Biotech, Inc. (NASDAQ:ADRO) shrinked -10.06% for the yearly performance.

Varex Imaging Corporation (NASDAQ:VREX)

Varex Imaging Corporation (NASDAQ:VREX) closed at $25.97 on the last trading session with an increase of 0.27%, whereas, it previously closed at $25.9. The company has a market capitalization of $1.06 Billion. The company traded shares of 310689 on the trading day while its three month average volume stands at 213.45 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Varex Imaging Corporation (NASDAQ:VREX) produced diluted EPS of 0.4. The EPS estimate for next year as estimated by analysts is at 1.79 while EPS for next quarter is estimated at 0.25. Earnings per Share growth for this year is reported at -24, while the analysts estimated the EPS growth for next year at 1.79% and Earnings growth for next 5 years stands at 5% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -32.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Varex Imaging Corporation (NASDAQ:VREX) is at 65.09 while the forward p/e is at 14.51. The P/S or Price to Sales ratio of Varex Imaging Corporation (NASDAQ:VREX) stands at 1.36 and Price to Book or P/B for the most recent quarter stands at 2.23. The Price to Free Cash Flow ratio or P/FCF is reported at 20.36. The quick ratio and the current ratio of Varex Imaging Corporation (NASDAQ:VREX) are reported at 1.1 and 2.5 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Varex Imaging Corporation (NASDAQ:VREX) stands at 1.5, 3.6 and 4.8 respectively

The trailing twelve month Revenue of Varex Imaging Corporation (NASDAQ:VREX) is reported at 780.6 Million with income of 15.5 Million. The outstanding shares of Varex Imaging Corporation (NASDAQ:VREX) are 40.84 Million. The institutional Ownership of the shares of 95.3 stands at 0.80%, this figure is increased 0.33 in the last six months. The insider ownership for the shares of Varex Imaging Corporation (NASDAQ:VREX) is ticked at 0.2%, the figure is plummeted -29.74% in the last six months.

Some other important financial aspects to be discussed here for Varex Imaging Corporation (NASDAQ:VREX) is the Mean Target Price estimated by the analysts which stands at 36.8. The 52 week high of Varex Imaging Corporation (NASDAQ:VREX) is placed at 35.00 and 52 week low is standing at 23.10.

Performance wise the shares of Varex Imaging Corporation (NASDAQ:VREX) fell down -10.2% for the week, it also fell -15.57% for the monthly performance, while for the quarter it went up -20.51%. The shares increase 0.78% for the half year and plummeted for the Year-To-Date performance. The shares of Varex Imaging Corporation (NASDAQ:VREX) shrinked -17.63% for the yearly performance.